Saudi Arabia Medical Nonwoven Disposables at USD 500 Million, Mölnlycke Doubles Jeddah Output, and SGN Line 5: Ken Research
As per Ken Research market modelling, Saudi Arabia's medical nonwoven disposables market reached USD 500 million in 2024, the largest single-country contributor to the USD 0.8 billion Middle East medical nonwoven market. Vision 2030 targets 120+ new hospitals and 84,000+ additional beds, while a 2023 government mandate requires disposable medical products across all healthcare facilities. The Saudi Arabia Medical Nonwoven Disposables Market Report covers segment forecasts and competitive benchmarking, published by Ken Research.
This analysis is based on Ken Research market modelling, U.S. Commercial Guide Saudi Arabia Healthcare (trade.gov), Vision 2030 Health Sector Transformation Programme, Trade Arabia Tamer Mölnlycke Care Phase II report (January 2026), and HPC MEA SGN Rabigh expansion news (May 2025).
USD 500 Million Market, SAR 214 Billion Health Budget, and 2023 Disposables Mandate Create Structural Demand
As per U.S. trade.gov, Saudi Arabia allocated SAR 214 billion (USD 57 billion) to health and social development in its 2024 national budget, representing 17 percent of total government expenditure. Vision 2030 plans over USD 65 billion in healthcare infrastructure through 2030. As per Ken Research, the 2023 government regulation mandating disposable medical products across all healthcare facilities creates a policy-driven demand floor. Surgical nonwovens lead by revenue with hospitals as the dominant end-user. The Middle East Medical Nonwoven Disposables Market covers the USD 0.8 billion regional context.
- Market scale: USD 500 million (2024); largest contributor to USD 0.8 billion Middle East market; Saudi Arabia's medical equipment market at USD 2 billion growing ~10 percent annually.
- Policy mandate: 2023 regulation mandates disposable products across all healthcare facilities; National IPC Manual (2018) mandates sterile barrier systems.
- Infrastructure pipeline: 120+ new hospitals and clinics; 84,000+ additional beds required; elderly population projected at 9 million by 2030.
Mölnlycke Doubles Jeddah Output to 500,000 Units, SGN Launches Reicofil 5 Line, and USD 12.8 Billion PPP Wave Accelerates Local Manufacturing
As per Trade Arabia (January 2026), Tamer Mölnlycke Care's Jeddah Third Industrial City factory completed Phase II and doubled production capacity from 250,000 to 500,000 units per year, inaugurated on January 29, 2026. Mölnlycke increased its stake in the joint venture from 33.3 percent to 60 percent in 2024, gaining majority control. As per HPC MEA (May 2025), Saudi German Nonwoven launched its fifth production line using Reicofil 5 spunmelt technology at its Rabigh facility for surgical masks and medical gowns. The government invested USD 26 million to enhance domestic melt blown fabric manufacturing. Over 100 PPP healthcare projects worth USD 12.8 billion are expected, with 19 active projects at USD 2.9 billion already underway.
- Mölnlycke expansion: Jeddah Phase II doubled output to 500,000 units/year (Jan 2026); stake raised to 60 percent; local production of surgical drapes, gowns, and wound care.
- SGN Line 5: Reicofil 5 spunmelt line launched at Rabigh (May 2025); produces surgical masks and medical gowns; USD 26 million government investment in melt blown capacity.
- PPP pipeline: 19 active PPP projects at USD 2.9 billion; 100+ expected totalling USD 12.8 billion; USD 1.5 billion allocated to healthcare IT.
Want segment-level data, player benchmarks, and Vision 2030 procurement pipeline for Saudi medical nonwovens? Download Sample Report to preview the full competitive and forecast dataset.
SFDA MDMA Mandate, 60+ Competing Manufacturers, and 25% Polypropylene Volatility Frame Market Dynamics
As per trade.gov, Saudi Arabia's SFDA requires Medical Device Marketing Authorization (MDMA) covering technical documentation, clinical data, and QMS audit. US FDA, EU MDR, and Japanese approvals are recognized, simplifying entry for certified manufacturers. As per Ken Research, over 60 manufacturers compete in the market, creating margin pressure, while polypropylene input costs fluctuate up to 25 percent. Key global players include Kimberly-Clark, Medline, Cardinal Health, and Berry Global; local producers include SAAF, Saudi Spun Bonded, and SGN.
- Regulatory entry: SFDA MDMA mandatory; US FDA, EU MDR, and Japanese approvals recognized; Vision 2030 to privatize 290 hospitals and 2,300 primary health centers.
- Competitive intensity: 60+ active manufacturers; polypropylene price volatility up to 25 percent; informal home healthcare awareness remains low.
- Local supply chain: SGN (Rabigh), SAAF, and Saudi Spun Bonded supplying domestic nonwoven fabrics; reduces import dependency for surgical product manufacturers.
Saudi Arabia Medical Nonwoven Outlook: USD 102 Billion Healthcare Market by 2035, 21 Health Clusters, and Geriatric Demand Wave
As per trade.gov, Saudi Arabia's total healthcare market is projected at USD 102 billion by 2035. Vision 2030 will establish 21 health clusters, each serving 1 million people, raising private sector healthcare from 25 percent to 35 percent via privatization of 290 hospitals and 2,300 primary health centers. As per Ken Research, the 9 million elderly by 2030 will drive sustained demand for incontinence and wound care nonwovens. The Saudi Arabia Medical Nonwoven Disposables Market Report maps the full segment roadmap through 2030.
- Healthcare scale: Total market at USD 102 billion by 2035; SAR 214 billion (17% of budget) allocated in 2024; 21 health clusters each serving 1 million people.
- Privatisation: 290 hospitals and 2,300 PHCs to be privatized; private sector share target raised from 25 percent to 35 percent by 2030.
- Geriatric demand: 9 million elderly projected by 2030; rising chronic disease burden expands wound care and incontinence nonwoven segments.
Ready for the full Saudi Arabia medical nonwoven competitive landscape, segment forecasts, and Vision 2030 procurement pipeline? Saudi Arabia Medical Nonwoven Disposables Market Report from Ken Research covers the complete picture.
Conclusion
Saudi Arabia's medical nonwoven disposables market at USD 500 million in 2024 is anchored by a 2023 mandatory disposables regulation, SAR 214 billion in health budget, and Mölnlycke doubling Jeddah output to 500,000 units/year. With 84,000+ hospital beds needed by 2030, 9 million elderly driving geriatric care demand, and SGN's Reicofil 5 line maturing domestic supply, the market is in a sustained multi-year growth cycle. Access the Saudi Arabia Medical Nonwoven Disposables Market Report from Ken Research for full forecasts and benchmarking.
Frequently Asked Questions
Q1: What is the size of Saudi Arabia's medical nonwoven disposables market?
As per Ken Research market modelling, Saudi Arabia's medical nonwoven disposables market reached USD 500 million in 2024, the largest contributor to the USD 0.8 billion Middle East market. The market spans surgical nonwovens (dominant), wound dressings, incontinence products, and hygiene nonwovens. Full segment data is in the Saudi Arabia Medical Nonwoven Disposables Market Report.
Q2: What is driving demand for medical nonwovens in Saudi Arabia?
As per Ken Research and trade.gov, the 2023 government mandate requiring disposable products across all healthcare facilities creates a structural demand floor. Vision 2030 will add 120+ hospitals and 84,000+ beds; the elderly population will reach 9 million by 2030; and Saudi Arabia invested USD 57 billion in health in 2024.
Q3: Who are the leading players in Saudi Arabia's medical nonwoven market?
As per Ken Research, global players include Kimberly-Clark, Medline Industries, Cardinal Health, Berry Global, and 3M. Tamer Mölnlycke Care (Mölnlycke 60% stake) manufactures locally in Jeddah at 500,000 units/year post Phase II (Jan 2026). Local fabric producers include SGN (Rabigh Line 5, May 2025), SAAF, and Saudi Spun Bonded. Full competitive data is in the Saudi Arabia Medical Nonwoven Disposables Market Report.
Q4: How does SFDA regulate medical nonwoven disposables in Saudi Arabia?
As per trade.gov, Saudi Arabia's SFDA requires Medical Device Marketing Authorization (MDMA) for all manufacturers, covering technical documentation, clinical data, and QMS audit. US FDA, EU MDR, and Japanese approvals are recognized, simplifying entry for certified manufacturers.
Q5: What is the outlook for Saudi Arabia's medical nonwoven market through 2030?
As per Ken Research and trade.gov, Saudi Arabia's total healthcare market is forecast at USD 102 billion by 2035. The 9 million elderly population by 2030 drives wound care and incontinence nonwoven demand. In-Kingdom manufacturing is expanding with Mölnlycke at 500,000 units/year and SGN Line 5 operational. Full analysis is in the Saudi Arabia Medical Nonwoven Disposables Market Report from Ken Research.
Comments
Post a Comment